Laboratory Corp. (LH) Reports In-Line Q2 EPS; Adjusts Q2 Outlook
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Price: $326.89 -1.39%
EPS Growth %: +11.2%
Financial Fact:
Diluted earnings per common share: 1.71
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +11.2%
Financial Fact:
Diluted earnings per common share: 1.71
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.80, in-line with the analyst estimate of $1.80. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion.
Now sees FY2013 EPS of $6.90 - $7.10, from prior expectations of $6.85 - $7.15 and the consensus of $7.09.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Now sees FY2013 EPS of $6.90 - $7.10, from prior expectations of $6.85 - $7.15 and the consensus of $7.09.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
